Subscribe To
Deciphera raises $150m via equity offering
Deciphera pharmaceuticals Inc (NASDAQ: DCPH) has priced an underwritten public offering of 5.25 millio...
April 27, 2022, 7:55 am
Stevanato group to report first quarter 2022 financial results on may 10, 2022
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnost...
April 27, 2022, 7:50 am
Aptinyx to report first quarter 2022 financial results on thursday, may 12, 2022
EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical compan...
April 27, 2022, 7:47 am
Healthy dividends: organic growth points north for west pharmaceutical services
West pharmaceutical Services is becoming a vital component of the healthcare industry. West has provide...
April 26, 2022, 11:09 pm
Intelgenx to participate in the 2022 bloom burton & co. healthcare investor conference
SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in ...
April 26, 2022, 4:45 pm
Why quoin pharmaceuticals stock is trading higher
Quoin pharmaceuticals (NASDAQ: QNRX) shares are trading higher Monday after the company announced it re...
April 25, 2022, 11:45 am
Nkarta stock skyrockets on heavy volume after upbeat results from cancer-treatment trial
Shares of Nkarta Inc. NKTX, +95.82% skyrocketed 92.8% in very active morning trading, enough to make the stock the biggest gainer and most active list...
April 25, 2022, 10:49 am
Catalyst pharmaceuticals to report first quarter 2022 financial results on may 10, 2022
The Company to Host a Conference Call and Webcast on May 11, 2022, at 8:30 AM ET The Company to Host a Conference Call and Webcast on May 11, 2022, at...
April 25, 2022, 8:03 am
Crinetics pharmaceuticals: endocrinology focus to pay off as multi-faceted pipeline makes progress
Shares have fallen by 15% since my 2019 recommendation. I provide a recap of the bullish thesis and recent events. Endocrinology is a unique field whe...
April 24, 2022, 10:39 am
Madrigal: clear path ahead
Among many non-alcoholic steatohepatitis (NASH) drug innovators, Madrigal pharmaceuticals is poised to ...
April 22, 2022, 2:09 pm
Is teva pharmaceuticals a brilliant contrarian pick?
Investing in this generic drugmaker would be a gamble, but there are reasons why it might be worth a look....
April 21, 2022, 9:05 am
Ampio pharma shares fall as fda rejects proposed change in knee osteoarthritis trial
Ampio pharmaceuticals Inc (NYSE: AMPE) received written responses from the FDA pursuant to a Type C me...
April 21, 2022, 6:29 am
Teva's (teva) schizophrenia drug gets crl from the fda
Teva pharmaceuticals (TEVA) and partner MedinCell's new drug application for risperidone to treat schiz...
April 20, 2022, 12:47 pm
Rockwell medical to present at noblecon18 investor conference
WIXOM, Mich. , April 20, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a bio...
April 20, 2022, 8:00 am
Fda rejects teva - medincell's schizophrenia candidate
Teva pharmaceutical Industries Ltd's (NYSE: TEVA) U.S. affiliate and MedinCell SA (OTC: MDCLF) have�...
April 20, 2022, 7:37 am
Atai life sciences to participate in upcoming april investor conference
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage bio...
April 19, 2022, 12:26 pm
Earnings: johnson & johnson misses on revenue, suspends vaccine sales guidance
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss earnings for Johnson & Johnson as well as the ...
April 19, 2022, 11:03 am
Ani pharmaceuticals to discuss first quarter 2022 financial results on may 10, 2022
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: A...
April 19, 2022, 6:50 am
Sage therapeutics to report first quarter 2022 financial results on tuesday, may 3, 2022
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company ...
April 19, 2022, 6:30 am
Verona pharma to report first quarter 2022 financial results and provide corporate update
LONDON and RALEIGH, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage bio...
April 19, 2022, 2:00 am